help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dickson, S. E.
Right arrow Articles by Fraser, H. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dickson, S. E.
Right arrow Articles by Fraser, H. M.
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 6 2339-2344
Copyright © 2000 by The Endocrine Society


Original Studies

Inhibition of Early Luteal Angiogenesis by Gonadotropin-Releasing Hormone Antagonist Treatment in the Primate

Sarah E. Dickson and Hamish M. Fraser

Medical Research Council Human Reproductive Sciences Unit, Centre for Reproductive Biology, Edinburgh, EH3 9ET, United Kingdom

Address correspondence and requests for reprints to: Sarah E. Dickson, Medical Research Council Human Reproductive Sciences Unit, Centre for Reproductive Biology, 37 Chalmers Street, Edinburgh, EH3 9ET, United Kingdom. E-mail: s.dickson{at}ed-rbu.mrc.ac.uk

Angiogenesis during luteal development is essential for normal lutein cell function, but the control of this process and the relationships between the steroidogenic and endothelial cells have still to be elucidated. The aim of this study was to: 1) quantify endothelial cell proliferation throughout the luteal phase of the marmoset ovulatory cycle; 2) determine the effect of gonadotropin withdrawal using GnRH antagonist treatment on the early luteal phase angiogenesis peak; and 3) describe the resultant morphological changes in the corpus luteum (CL). Ovaries were collected during the early, mid-, and late luteal phase, and changes in angiogenic activity were determined by quantification of bromodeoxyuridine incorporation. Animals were treated with a GnRH antagonist, on luteal days 1 and 2, and ovaries were collected on day 3. A proliferation index was obtained by counting the number of bromodeoxyuridine immunopositive cells in luteal sections. Cell proliferation was maximal in the early luteal phase and fell significantly in the mid- and late CL. GnRH antagonist treatment reduced the early luteal phase proliferation peak by 90%, suppressed plasma progesterone, and severely disrupted lutein cell morphology. These results demonstrate that the intense angiogenesis in the early primate CL is dependent on gonadotropin stimulation of lutein cells.




This article has been cited by other articles:


Home page
Toxicol PatholHome page
G. F. Weinbauer, M. Niehoff, M. Niehaus, S. Srivastav, A. Fuchs, E. Van Esch, and J. M. Cline
Physiology and Endocrinology of the Ovarian Cycle in Macaques
Toxicol Pathol, December 1, 2008; 36(7_suppl): 7S - 23S.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
R S Robinson, A J Hammond, G E Mann, and M G Hunter
A novel physiological culture system that mimics luteal angiogenesis
Reproduction, March 1, 2008; 135(3): 405 - 413.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
A. Silvestri and H. M Fraser
Oestrogen and progesterone receptors in the marmoset endometrium: changes during the ovulatory cycle, early pregnancy and after inhibition of vascular endothelial growth factor, GnRH or ovariectomy
Reproduction, August 1, 2007; 134(2): 341 - 353.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
L. S. Sleer and C. C. Taylor
Platelet-Derived Growth Factors and Receptors in the Rat Corpus Luteum: Localization and Identification of an Effect on Luteogenesis
Biol Reprod, March 1, 2007; 76(3): 391 - 400.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
H. M Fraser, H. Wilson, C. Wulff, J. S Rudge, and S. J Wiegand
Administration of vascular endothelial growth factor Trap during the 'post-angiogenic' period of the luteal phase causes rapid functional luteolysis and selective endothelial cell death in the marmoset.
Reproduction, October 1, 2006; 132(4): 589 - 600.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
J Aguilar, H M Fraser, H Wilson, E Clutton, D J Shaw, and E D Watson
Temporal relationship between proliferating and apoptotic hormone-producing and endothelial cells in the equine corpus luteum
Reproduction, July 1, 2006; 132(1): 111 - 118.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. M. Fraser, H. Wilson, K. D. Morris, I. Swanston, and S. J. Wiegand
Vascular Endothelial Growth Factor Trap Suppresses Ovarian Function at All Stages of the Luteal Phase in the Macaque
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5811 - 5818.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
P D Taylor, S G Hillier, and H M Fraser
Effects of GnRH antagonist treatment on follicular development and angiogenesis in the primate ovary
J. Endocrinol., October 1, 2004; 183(1): 1 - 17.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
H. E. Turner, A. L. Harris, S. Melmed, and J. A. H. Wass
Angiogenesis in Endocrine Tumors
Endocr. Rev., October 1, 2003; 24(5): 600 - 632.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Kohen, O. Castro, A. Palomino, A. Munoz, L. K. Christenson, W. Sierralta, P. Carvallo, J. F. Strauss III, and L. Devoto
The Steroidogenic Response and Corpus Luteum Expression of the Steroidogenic Acute Regulatory Protein after Human Chorionic Gonadotropin Administration at Different Times in the Human Luteal Phase
J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3421 - 3430.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. J. Rowe, K. D. Morris, R. Bicknell, and H. M. Fraser
Angiogenesis in the Corpus Luteum of Early Pregnancy in the Marmoset and the Effects of Vascular Endothelial Growth Factor Immunoneutralization on Establishment of Pregnancy
Biol Reprod, October 1, 2002; 67(4): 1180 - 1188.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Wulff, S. E. Dickson, W. C. Duncan, and H. M. Fraser
Angiogenesis in the human corpus luteum: simulated early pregnancy by HCG treatment is associated with both angiogenesis and vessel stabilization
Hum. Reprod., December 1, 2001; 16(12): 2515 - 2524.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Wulff, H. Wilson, J. S. Rudge, S. J. Wiegand, S. F. Lunn, and H. M. Fraser
Luteal Angiogenesis: Prevention and Intervention by Treatment with Vascular Endothelial Growth Factor TrapA40
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3377 - 3386.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society